MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||

Income Overview

Revenue
$26,861K
Net Income
-$7,273K
Net Profit Margin
-27.08%
EPS
-$0.71
Unit: Thousand (K) dollars
Revenue Breakdown
    • Diagnostic Tests
    • Development Services
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenues
26,861
25,555
28,755
21,768
Direct costs and expenses
4,820
4,205
4,879
4,106
Research and development
3,135
3,285
2,870
2,992
Sales, marketing, general and administrative
24,282
24,261
22,972
21,714
Impairment loss on intangible assets
12
5
1
7
Total operating expenses
32,249
31,756
30,722
28,819
Loss from operations
-5,388
-6,201
-1,967
-7,051
Interest expense
1,982
1,977
2,059
2,074
Change in fair value of warrant liability, net
-
-
-140*
-
Other income , net
-
-
-94*
-
Other income, net
97
385
-
409
Total other expense
-1,885
-1,592
-2,013
-1,665
Net loss
-7,273
-7,793
-3,980
-8,716
Basic EPS
-0.71
-0.81
-0.527
-1.16
Diluted EPS
-0.71
-0.81
-0.527
-1.16
Basic Average Shares
10,296,000
9,656,000
7,551,000*
7,500,000
Diluted Average Shares
10,296,000
9,656,000
7,551,000*
7,500,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

BDSX Income Statement Sankey DiagramSankey diagram visualizing BDSX income statement for the periodNet loss-$7,273K (36.58%↑ Y/Y)Diagnostic Tests$25,349K (41.63%↑ Y/Y)Development Services$1,512K (-28.68%↓ Y/Y)Loss from operations-$5,388K (44.56%↑ Y/Y)Total other expense-$1,885K (-7.78%↓ Y/Y)Revenues$26,861K (34.18%↑ Y/Y)Other income, net$97K (90.20%↑ Y/Y)Total operatingexpenses$32,249K (8.45%↑ Y/Y)Interest expense$1,982K (4.43%↑ Y/Y)Sales, marketing,general and...$24,282K (8.35%↑ Y/Y)Direct costs andexpenses$4,820K (19.57%↑ Y/Y)Research and development$3,135K (-4.10%↓ Y/Y)Impairment loss onintangible assets$12K (-53.85%↓ Y/Y)

BIODESIX INC (BDSX)

BIODESIX INC (BDSX)